Radiology evaluations and interventions: Diagnostic and interventional radiology procedures
Study summary
The purpose of this study is to collect all radiological data which evaluated with clinical data may help assess malignancy and prognosis of pancreatic disease.This registry aims to collect retrospective data from 2014 and prospective data until 2027 with a maximum follow-up of 3 years per patient.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* ≥18 years of age
* Patients with suspect (planned for investigation) or diagnosed pancreatic cancer at any stage.
* able and willing to sign informed consent
Exclusion Criteria:
* Patients with non-primary pancreatic disease
Primary outcome measure(s)
Progression- free survival — From date of intervention until the date of first documented progression, up to a maximum of 3 years Time from start of observation to disease progression
Local progression free survival — From date of intervention until the date of first documented local progression assessed up to a maximum of 3 years Time between (start of) a locoregional treatment and local disease progression
Trial sites (1)
Facility
City
Region
Status
Department of Radiology, IRCCS Ospedale San Raffaele
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
